3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
13
Lymphoid
12
Gynecologic
7
Breast
7
Genitourinary
6
Myeloid
5
Dermatologic
5
Thoracic
4
Sarcoma
3
Other solid neoplasm
3
Gastrointestinal
3
Plasma cell
2
CNS
2
Other neoplasm
1
Head & Neck
1
Conditions
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Precancerous Conditions
1
Interventions
Biopsy
4
Cyclophosphamide
3
Microarray Analysis
2
Methylprednisolone
2
Filgrastim
2
Colposcopy
2
Carboplatin
2
toripalimab
1
tipifarnib
1
sargramostim
1
sapanisertib
1
pyroxamide
1
pirfenidone
1
penpulimab
1
palbociclib
1
liposomal doxorubicin
1
iodixanol
1
human papillomavirus vaccine, TA
1
artemisinin
1
arginine butyrate
1
Zoledronic Acid
1
Vincristine
1
Video-Assisted Surgery
1
Topotecan
1
Tetradecanoylphorbol Acetate
1
Taxes
1
Tacrolimus
1
Specimen Handling
1
Sorafenib
1
Sodium Chloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Flow Cytometry
×
Other neoplasm
×
Clear all
NCT00629577
2017-02-01
SAGE
British Columbia Cancer Agency
Phase 1
Terminated
50 enrolled